SZShaoran Zhang

Shaoran Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shaoran Zhang has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Nan

    International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, Guangdong, China

    1 shared publication
  • Ling Jiang

    National Key Laboratory of Germplasm Innovation and Utilization of Fruit and Vegetable Horticultural Crops, College of Horticulture and Forestry, Huazhong Agricultural University

    1 shared publication
  • Ping Zhan

    Ministry of Education Key Laboratory of Plant Biology, Huazhong Agricultural University, Wuhan 430070, China

    1 shared publication

Latest Publications

  • Open Access

    Evaluation of Bronopol and Disulfiram as Potential Candidatus Liberibacter asiaticus Inosine 5′-Monophosphate Dehydrogenase Inhibitors by Using Molecular Docking and Enzyme Kinetic

    by Jing Nan, Shaoran Zhang, Ping Zhan, Ling Jiang

    Citrus huanglongbing (HLB) is a destructive disease that causes significant damage to many citrus producing areas worldwide. To date, no strategy against this disease has been established. Inosine 5′-monophosphate dehydrogenase (IMPDH) plays crucial roles in the de novo synthesis of guanine nucleotides. This enzyme is used as a potential target to treat bacterial infection. In this study, the crystal structure of a deletion mutant of CLas IMPDHΔ98-201 in the apo form was determined. Eight known bioactive compounds were used as ligands for molecular docking. The results showed that bronopol and disulfiram bound to CLas IMPDHΔ98-201 with high affinity. These compounds were tested for their inhibition against CLas IMPDHΔ98-201 activity. Bronopol and disulfiram showed high inhibition at nanomolar concentrations, and bronopol was found to be the most potent molecule (Ki = 234 nM). The Ki value of disulfiram was 616 nM. These results suggest that bronopol and disulfiram can be considered potential candidate agents for the development of CLas inhibitors.